Lysosomal Storage Disorder
Gene: GLA
Well established gene-disease association.
Deficient or absent activity of the lysosomal enzyme alpha-galactosidase A. This enzymatic defect leads to the systemic accumulation of globotriaoslyceramide (Gb3) and related glycosphingolipids in the plasma and cellular lysosomes of vessels, nerves, tissues, and organs throughout the body. Clinical manifestations include progressive renal failure, cardiac disease, cerebrovascular disease, small-fiber peripheral neuropathy, and skin lesions.Created: 8 Apr 2021, 9:39 p.m. | Last Modified: 8 Apr 2021, 9:39 p.m.
Panel Version: 0.109
Mode of inheritance
X-LINKED: hemizygous mutation in males, biallelic mutations in females
Phenotypes
Fabry disease, MIM# 301500
Publications
Gene: gla has been classified as Green List (High Evidence).
Phenotypes for gene: GLA were changed from Fabry disease, MIM# 301500 to Fabry disease, MIM# 301500; MONDO:0010526
Phenotypes for gene: GLA were changed from to Fabry disease, MIM# 301500
Publications for gene: GLA were set to
Mode of inheritance for gene: GLA was changed from Unknown to X-LINKED: hemizygous mutation in males, biallelic mutations in females
gene: GLA was added gene: GLA was added to Storage Disorder_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: GLA was set to Unknown